Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating YAP/TAZ-mediated regulation of antiviral signaling in lung cancer chemoresistance

FY 2022-23

Summary
Lung cancer is the deadliest cancer in Canada and nearly all patients are treated with chemotherapies that kill cancer cells. While they work well initially, over time tumours adapt to escape their toxic effects, becoming resistant to these drugs. This state, known as chemoresistance, is a major barrier to improving lung cancer survival rates. My project aims to better understand the biology of chemoresistance to learn how to make chemotherapy treatment work better. One of the ways chemotherapies work is by triggering an antiviral-like response in cancer cells. Antiviral signaling is used by cells to defend against viral attack. The antiviral response leads to the production of signaling proteins called interferons that are toxic to cancer cells and help the immune system recognize and kill tumours. Interestingly, two proteins called YAP and TAZ can promote chemoresistance and influence antiviral signaling suggesting these two processes might be connected. However, it is not known whether YAP/TAZ promotes chemoresistance by regulating antiviral response. I hypothesize that blocking the function of YAP/TAZ will boost antiviral signaling in tumours and make chemotherapy more effective at killing them. To address this hypothesis, I will test the response of lung cancer cells to different chemotherapies and measure how they upregulate antiviral signaling. I will also block YAP/TAZ function to see how this affects antiviral signaling and lung cancer sensitivity to chemotherapy treatment. These experiments will help us determine whether loss of YAP/TAZ function boosts antiviral signaling and enhances the efficacy of chemotherapy. The findings from my project could inform new strategies to overcome chemoresistance and increase the effectiveness of chemotherapy in lung cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486350
Name
Khavkine Binstock Sharon S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating YAP/TAZ-mediated regulation of antiviral signaling in lung cancer chemoresistance
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antiviral Signaling; Chemoresistance; Lung Cancer; Yap/Taz
Abstract
Lung cancer is the deadliest cancer in Canada and nearly all patients are treated with chemotherapies that kill cancer cells. While they work well initially, over time tumours adapt to escape their toxic effects, becoming resistant to these drugs. This state, known as chemoresistance, is a major barrier to improving lung cancer survival rates. My project aims to better understand the biology of chemoresistance to learn how to make chemotherapy treatment work better. One of the ways chemotherapies work is by triggering an antiviral-like response in cancer cells. Antiviral signaling is used by cells to defend against viral attack. The antiviral response leads to the production of signaling proteins called interferons that are toxic to cancer cells and help the immune system recognize and kill tumours. Interestingly, two proteins called YAP and TAZ can promote chemoresistance and influence antiviral signaling suggesting these two processes might be connected. However, it is not known whether YAP/TAZ promotes chemoresistance by regulating antiviral response. I hypothesize that blocking the function of YAP/TAZ will boost antiviral signaling in tumours and make chemotherapy more effective at killing them. To address this hypothesis, I will test the response of lung cancer cells to different chemotherapies and measure how they upregulate antiviral signaling. I will also block YAP/TAZ function to see how this affects antiviral signaling and lung cancer sensitivity to chemotherapy treatment. These experiments will help us determine whether loss of YAP/TAZ function boosts antiviral signaling and enhances the efficacy of chemotherapy. The findings from my project could inform new strategies to overcome chemoresistance and increase the effectiveness of chemotherapy in lung cancer.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Khavkine Binstock, Sharon S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~